Skip to main content
CIN- L67120MH1995PLC084899
 

Generate password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID



Asston Pharmaceuticals Ltd.

NSE : BSE : 544445 ISIN CODE : INE0SJX01015Industry : Pharmaceuticals

News

  • Asston Pharma. - Audited Financial Results For The Financial Year Ended 31St March, 2026. 29 May 2026 | 22:03 | Dion Global

    Audited Financial Results for the Financial Year ended 31st March 2026more...

  • Asston Pharma. - Audited Financial Results For The Financial Year Ended 31St March, 2026. 29 May 2026 | 22:01 | Dion Global

    Audited Financial Results for the Financial Year ended 31st March 2026more...

  • Asston Pharma. - Board Meeting Outcome for Outcome Of The Board Meeting Held On 29Th May, 2026 29 May 2026 | 21:47 | Dion Global

    Outcome of Board Meeting scheduled to be held on 29th May 2026more...

  • Asston Pharma. - Board Meeting Intimation for Approving Audited Financial Ressults 21 May 2026 | 20:50 | Dion Global

    Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia t...more...

  • Asston Pharma. - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 30 Apr 2026 | 22:01 | Dion Global

    Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Asston Pharmaceut...more...

  • Asston Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report 28 Apr 2026 | 18:10 | Dion Global

    Voting Result and Scrutinizer s Report for EGM held on 28th April 2026 through VC-OAVMmore...

  • Asston Pharma. - Shareholder Meeting / Postal Ballot-Outcome of EGM 28 Apr 2026 | 13:12 | Dion Global

    Outcome and Proceedings of the Extraordinary General Meeting held on 28th April 2026 through (VC-OAVM).more...

  • Asston Pharma. has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026 21 Apr 2026 | 16:10 | Dion Global

    As of March 2026 50.66% is owned by Indian Promoters and 49.34% by Public. Top three Promoters holding highest number of shares of Asston Ph...more...

  • Asston Pharma. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 14 Apr 2026 | 16:23 | Dion Global

    Certificate under regulation 74(5) of SEBI (Depositories Participants) Regulation 2018more...

  • Asston Pharma. - Record Date 06 Apr 2026 | 18:27 | Dion Global

    Intimation of record date i.e. 17th April 2026 for the E-voting process pursuant to the Extraordinary General Meeting scheduled to be held o...more...

  • Asston Pharma. - Notice Of Extraordinary General Meeting 06 Apr 2026 | 18:22 | Dion Global

    Please find attached the Notice of Extraordinary General Meeting scheduled to be held on 28th April 2026more...

  • Asston Pharma. - The Extraordinary General Meeting Is Scheduled On Tuesday, 28Th April, 2026. 30 Mar 2026 | 17:01 | Dion Global

    Please find attached the outcome of the Board Meeting and the EGM date.more...

  • Asston Pharma. - Announcement under Regulation 30 (LODR)-Change in Management 30 Mar 2026 | 16:51 | Dion Global

    Details about the change in management.more...

  • Asston Pharma. - Announcement under Regulation 30 (LODR)-Meeting Updates 30 Mar 2026 | 16:46 | Dion Global

    Meeting Updatemore...

  • Asston Pharma. - Board Meeting Outcome for Outcome Of The Board Meeting Schedule To Be Held On 30Th March, 2026 30 Mar 2026 | 16:32 | Dion Global

    Outcome of the Board Meeting Schedule to be held on 30th March 2026more...

  • Asston Pharma. - Board Meeting Intimation for Scheduled To Be Held On 30Th March, 2026 At 3:00 P.M. At The Registered Office 25 Mar 2026 | 18:41 | Dion Global

    Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/03/2026 inter alia t...more...

  • Asston Pharma. - Announcement under Regulation 30 (LODR)-Change in Management 02 Mar 2026 | 17:03 | Dion Global

    Appointment of M/s Panchal S K and Associates as the Statutory Auditor of the Company.more...

  • Asston Pharma. - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s 02 Mar 2026 | 16:58 | Dion Global

    Appointment of M/s Panchal S K and Associates as the Statutory Auditor of the Company.more...

  • Asston Pharma. - Cancellation of Board Meeting 07 Feb 2026 | 14:29 | Dion Global

    The Board Meeting to be held on 07/02/2026 Stands Cancelled.more...

  • Asston Pharma. - Announcement under Regulation 30 (LODR)-Change in Management 29 Jan 2026 | 18:47 | Dion Global

    Resignation of statutory auditormore...

DOW Jones45473.550.16%
Nasdaq21794.160.43%
S&P 5006496.040.22%
Nikkei 22543643.811.45%
Hang Seng25633.910.85%
Shanghai Composite3826.840.38%
Sensex76200.68-1.16%
NSE Index23824.1-1.15%
B500DIVL503479.7-1.56%
BSE 1000 10760-1.03%
BSE 100LCTMC8982.47-1.17%
BSE Auto 58478.05-0.86%

Commodity

Gold144323-1.65%
Silver227482-4.34%
Copper1303.85219.73%
Crude Oil69798.83%
Lead207.5554.43%
Mentha Oil1104.83.50%
Nickel1696121.15%

Currency

USD/INR 94.49(0.01 %)
GBP/INR 124.85(0.19 %)
EUR/INR 108.25(0.20 %)
JPY/INR 0.58(-0.93 %)
CAD/INR 67.68(0.00 %)
HKD/INR 12.09(0.01 %)